Note The 2026 financial year is from 1 July 2025 – 30 June 2026. All financial figures are reported in USD unless otherwise indicated. Disclaimer This Impact Report is produced by CSL Limited (ACN 051 588 348) for general information purposes only. While effort has been made to ensure the accuracy and completeness of the information at the time of publication, CSL makes no representations or warranties of any kind, express or implied, about the content’s accuracy, reliability, or suitability. Certain figures in this report are estimates or have been rounded and are indicative only. Financial figures are drawn from CSL's FY26 results and are reported in USD unless otherwise indicated. All content is the property of CSL or its licensors and is protected by applicable intellectual property laws. Reproduction is permitted only for personal, non-commercial use and must retain all proprietary notices. Some statements about products, registered product indications or procedures may differ in certain countries. Therefore, always consult the country-specific product information, package leaflets or instructions for use. For more information, please contact a local CSL representative. Brand names designated by a ® or a ™ throughout this publication are trademarks either owned by and/or licensed to CSL or its affiliates. Not all brands mentioned are used or registered as trademarks in all countries served by CSL. 2 | CSL IMPACT REPORT 2026 Our Contents 03 Introduction About CSL 09For Patients Putting Patients First, Together 21 For Science Advancing Science and Innovation 27 For Society Strengthening Health Systems and Communities 35 Looking Ahead Reflecting on the Future
RkJQdWJsaXNoZXIy MjE2NDg3